Key points from article :
Revita® duodenal mucosal resurfacing (DMR) is a new therapy for poorly controlled diabetes.
Thickening of the duodenal lining (mucosa) is the likely reason for reduced insulin sensitivity.
Puts a balloon catheter via mouth and deliver thermal energy to duodenal mucosa.
Flushes out damaged duodenal mucosa allowing new duodenal mucosa to regenerate.
Significantly improved blood glucose control, liver insulin sensitivity 3 months later.
70 patients participated in this randomized, sham-controlled clinical trial REVITA-2.
By Institute of Diabetes, Endocrinology and Obesity to be published in Journal of the Endocrine Society.
